GHK-Cu: a copper peptide where the cream is the evidence

GHK-Cu — glycyl-L-histidyl-L-lysine bound to copper — is unusual among frontier peptides because its most-evidenced form is the one you can buy at a beauty counter. It’s a small copper-binding tripeptide that occurs naturally in human plasma (and declines with age), and it’s been studied for decades as a skin, hair, and wound-repair agent. The useful way to think about it is as two very different products wearing the same name: a topical cosmetic, which has small but real human data, and an injectable “systemic anti-aging” peptide, which does not. Keeping those apart is the whole task.

What it does

GHK-Cu’s mechanism is genuinely interesting. It delivers copper — a cofactor for enzymes involved in building connective tissue — and, in cell and animal models, it stimulates collagen and elastin synthesis, activates tissue-repair and antioxidant pathways, and supports wound healing. Gene-expression profiling has shown it nudges a broad set of regenerative pathways. That’s a coherent, well-characterized mechanism, and it’s why the molecule has stayed in the research literature far longer than most peptide fads.

But mechanism is grade-D evidence. The question that matters is whether it does anything measurable in actual humans — and there, the answer depends entirely on how you’re using it.

What the evidence shows — topical is the strong part

The topical cosmetic data is the best part of the GHK-Cu story, and it’s worth being precise about how good it is: real, but modest. Several small placebo-controlled human studies — facial creams, eye-area creams, typically around a dozen to several dozen women over 12 weeks — found that GHK-Cu improved skin laxity, clarity, firmness, fine lines, and density versus control creams, and in one comparison outperformed vitamin C and retinoic acid on collagen. These are genuine human trials with genuine (if cosmetic) endpoints.

They’re also small, industry-adjacent, and measuring appearance rather than any clinical outcome. So the fair grade is C: better human support than most things in this tier, well short of the deep evidence behind, say, a topical retinoid. If you’re curious, a GHK-Cu serum is a reasonable, low-stakes thing to try.

The injectable, systemic “anti-aging” use is a completely different claim, and the evidence collapses under it. The reviews are explicit that human data are essentially topical only; systemic and dietary uses are floated as “a possible direction for future research” — which is a polite way of saying unproven. There are no human trials showing that injecting GHK-Cu makes you younger, heals you faster systemically, or regenerates anything internal. That version is grade D and, on top of the missing evidence, is sold as a gray-market vial of unknown purity.

Who it’s for, and how to use it sensibly

The topical form is a low-risk OTC cosmetic. If you want to try it, use a copper-peptide serum from an established brand, patch-test first (copper peptides can occasionally irritate), and set expectations at “modest cosmetic improvement,” not transformation. A couple of practical notes: some routines advise not layering GHK-Cu with strong actives like high-dose vitamin C in the same application, as certain combinations can inactivate or irritate.

If what you actually want is the best-evidenced anti-aging skincare, the unglamorous answers still win: daily sunscreen and a retinoid have far deeper human data than any peptide. GHK-Cu can sit alongside them as a reasonable add-on, not a replacement.

The honest bottom line

GHK-Cu is the rare frontier peptide where the low-risk version is also the evidenced one. As a topical cream, it has small but real human data and is a fine, cheap thing to try if you’re curious — grade C, verdict context leaning toward “sure, consider it.” As an injected systemic anti-aging peptide, it’s unproven, gray-market, and a different product entirely — the topical studies say nothing about it. Use the cream if you like; leave the syringe alone.